Identifying microbial signatures for patients with postmenopausal osteoporosis using gut microbiota analyses and feature selection approachesOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study characterized gut microbiota signatures in postmenopausal osteoporosis and tested whether bacteria could classify the disease. It also compared microbial links to bone density at two skeletal sites. Fecal samples were profiled by 16S rRNA V3-V4 sequencing. Bone mineral density and blood biochemistry were measured for every participant. Two feature-selection methods, the maximal information coefficient and XGBoost with SHAP, identified disease-related microbial features.
Who was studied?
The cohort was 58 postmenopausal women in Xi'an, China: 21 with postmenopausal osteoporosis and 37 controls. Average age was about 57 years. Osteoporosis was defined by a bone density T-score below -2.5. None of the participants had a history of fractures. Women with diabetes, secondary osteoporosis, or major organ disease were excluded, and recent antibiotic and probiotic users were avoided.
What were the most important findings?
Overall diversity was similar between groups, but community structure differed on unweighted UniFrac distance (p = 0.025). Fusobacteria was higher in osteoporosis (0.08 versus 0.03 percent, p = 0.0395). Ruminococcaceae was lower in patients (25.64 versus 34.99 percent). Microbial composition correlated more strongly with total hip bone density than lumbar spine. A logistic model combining phylum Fusobacteria and one bacterial family separated patients from controls with an AUC of 0.7709, which was highly significant.
What are the greatest implications of this study?
The findings support a link between gut dysbiosis and postmenopausal bone loss and suggest microbial markers could aid osteoporosis screening. Stronger correlations at the total hip highlight that microbiome-bone relationships may vary by skeletal site, a point relevant to clinical interpretation. The sample was small and based only on fecal 16S sequencing, so larger studies with diet and lifestyle data are needed to confirm the markers.